Influenza Virus and Vaccination
- PMID: 32192196
- PMCID: PMC7157237
- DOI: 10.3390/pathogens9030220
Influenza Virus and Vaccination
Abstract
Influenza virus infections represent a serious public health problem causing contagious respiratory disease and substantial morbidity and mortality in humans, resulting in a considerable economic burden worldwide. Notably, the number of deaths due to influenza exceeds that of any other known pathogen. Moreover, influenza infections can differ in their intensity, from mild respiratory disease to pneumonia, which can lead to death. Articles in this Special Issue have addressed different aspects of influenza in human health, and the advances in influenza research leading to the development of better therapeutics and vaccination strategies, with a special focus on the study of factors associated with innate or adaptive immune responses to influenza vaccination and/or infection.
Keywords: Influenza virus; adaptive immunity; immune response; influenza vaccine; innate immunity; pandemic; universal vaccines; vaccination.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics.Front Microbiol. 2020 Feb 7;11:135. doi: 10.3389/fmicb.2020.00135. eCollection 2020. Front Microbiol. 2020. PMID: 32117155 Free PMC article. Review.
-
[Influenza, an existing public health problem].Salud Publica Mex. 2006 May-Jun;48(3):244-67. doi: 10.1590/s0036-36342006000300009. Salud Publica Mex. 2006. PMID: 16813133 Review. Spanish.
-
Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.J Virol. 2015 Dec 16;90(5):2544-50. doi: 10.1128/JVI.02598-15. J Virol. 2015. PMID: 26676789 Free PMC article.
-
Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.J Immunol. 2016 Jun 15;196(12):5014-23. doi: 10.4049/jimmunol.1502632. Epub 2016 May 6. J Immunol. 2016. PMID: 27183611 Free PMC article.
-
Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.J Virol. 2017 Nov 14;91(23):e01579-17. doi: 10.1128/JVI.01579-17. Print 2017 Dec 1. J Virol. 2017. PMID: 28931689 Free PMC article.
Cited by
-
Identification of Amino Acid Residues Required for Inhibition of Host Gene Expression by Influenza Virus A/Viet Nam/1203/2004 H5N1 PA-X.J Virol. 2022 Mar 9;96(5):e0040821. doi: 10.1128/JVI.00408-21. Epub 2021 Apr 14. J Virol. 2022. PMID: 33853954 Free PMC article.
-
β-Glucan Induces Distinct and Protective Innate Immune Memory in Differentiated Macrophages.J Immunol. 2021 Dec 1;207(11):2785-2798. doi: 10.4049/jimmunol.2100107. Epub 2021 Nov 5. J Immunol. 2021. PMID: 34740960 Free PMC article.
-
Structure-activity relationship studies in substituted sulfamoyl benzamidothiazoles that prolong NF-κB activation.Bioorg Med Chem. 2021 Aug 1;43:116242. doi: 10.1016/j.bmc.2021.116242. Epub 2021 May 30. Bioorg Med Chem. 2021. PMID: 34274759 Free PMC article.
-
Anti-Influenza Virus Study of Composite Material with MIL-101(Fe)-Adsorbed Favipiravir.Molecules. 2022 Mar 31;27(7):2288. doi: 10.3390/molecules27072288. Molecules. 2022. PMID: 35408686 Free PMC article.
-
Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes.Viruses. 2021 Apr 17;13(4):698. doi: 10.3390/v13040698. Viruses. 2021. PMID: 33920517 Free PMC article.